Doxycycline Versus Standard Care to Prevent Seroma Formation
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01188954|
Recruitment Status : Withdrawn (The recruitment process was slower than expected.)
First Posted : August 26, 2010
Last Update Posted : April 14, 2015
Information provided by (Responsible Party):
John P Nabagiez, MD, Northwell Health
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Recruitment Status :||Withdrawn|
|Estimated Primary Completion Date :||November 2012|
|Actual Study Completion Date :||November 2012|
Caliendo MV, Lee DE, Queiroz R, Waldman DL. Sclerotherapy with use of doxycycline after percutaneous drainage of postoperative lymphoceles. J Vasc Interv Radiol. 2001 Jan;12(1):73-7.
Swan MC, Furniss D, Cassell OC. Surgical management of metastatic inguinal lymphadenopathy. BMJ. 2004 Nov 27;329(7477):1272-6. Review.